Skip to content
Home
Close Home
Open Home
Journal information
Editorial board
Operations manual
Editorial policies
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Close Read
Open Read
Archive
TOC Alert
Current issue
Information
Close Information
Open Information
Editorial & Peer Review
Ethical policies
Funding
Complaints and appeals
Open access and licensing
Authors
Sponsorship
Contact
Publish
Close Publish
Open Publish
Instructions to authors
Online submission
Home
Journal Information
Editorial Board
Operations Manual
Editorial Polices
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Archive
Toc Alert
Current issue
Information
Editorial & Peer review
Ethical policies
Funding
Procedure for complaints and/or appeals
Open access & Licensing
Authors
Sponsors
Contact
Publish
Authors Instructions
Online submission
Home
Journal Information
Editorial Board
Operations Manual
Editorial Polices
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Archive
Toc Alert
Current issue
Information
Editorial & Peer review
Ethical policies
Funding
Procedure for complaints and/or appeals
Open access & Licensing
Authors
Sponsors
Contact
Publish
Authors Instructions
Online submission
ES
EN
0,00
€
0
Cart
TOC Alert
Volume 20 – Number 4
New Dual Combination of Dolutegravir-Rilpivirine for Switching to Maintenance Antiretroviral Therapy
Rebound in Sexually Transmitted Infections Following the Success of Antiretrovirals for HIV/AIDS
Overcoming Obstacles in Lipid-lowering Therapy in Patients with HIV – A Systematic Review of Current Evidence
Toward the Cure of HIV-1 Infection: Lessons Learned and Yet to be Learned as New Strategies are Developed
Economic Impact of HIV in the Highly Active Antiretroviral Therapy Era – Reflections Looking Forward
Hepatitis Delta Could Be More Frequent than Previously Thought
Longer Life Expectancy but still Accelerating Aging in HIV Patients under Antiretroviral Therapy
Hepatitis E Virus, the Uninvited Intruder in Western Kitchens
Should HIV Patients be concerned about Occult Hepatitis B?
HIV Guidelines